Evidence map›Paper›PMID 41868238›Full record

ArticleFrontiers in medicine2026

One-year survival rate and factors associated with stage IV colorectal cancer at National General Hospital in Indonesia.

Ardy Wildan, Eunike Vania Christabel, Ikhwan Rinaldi, Murdani Abdullah, Dadang Makmun

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ardy WildanDepartment of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Jakarta, Indonesia.
Eunike Vania ChristabelDepartment of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Jakarta, Indonesia.
Ikhwan RinaldiDivision of Hematology and Medical Oncology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Jakarta, Indonesia.
Murdani AbdullahDivision of Gastroenterology, Pancreatobilliary, and Digestive Endoscopy, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Jakarta, Indonesia.
Dadang MakmunDivision of Gastroenterology, Pancreatobilliary, and Digestive Endoscopy, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat, Jakarta, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate one-year survival and identify mortality-associated factors in stage IV colorectal cancer patients in Indonesia. Patients and methods: A retrospective cohort study was conducted using medical records of 214 patients aged ≥18 years who were diagnosed with stage IV CRC at Cipto Mangunkusumo National General Hospital between January 2018 and May 2020. Variables analyzed included demographic characteristics, body mass index (BMI), and chemotherapy status. Survival analysis was performed using the Kaplan-Meier method and Cox proportional hazards model. Results: Key findings included a one-year mortality rate of 53.3% and a median survival of 9.0 months (IQR 3.0-12.0). Most patients were under 60 years old (66.8%), and 47% were underweight (BMI < 18.5 kg/m Conclusion: This study demonstrates poor one-year survival among stage IV colorectal cancer patients in Indonesia. Underweight status and non-receipt of chemotherapy were independently associated with higher mortality; however, chemotherapy status likely reflects underlying patient fitness and disease severity rather than a direct causal effect. These findings highlight the challenges of late presentation, poor nutritional status, and limited access to systemic therapy in resource-limited settings.

Indexed as

associated factorscolorectal cancermetastatic colorectal cancerone-year survivalstage IV colorectal cancer

Identifiers

PMID41868238
PMCPMC13001645

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.